Company profile for Insulet Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, wit...
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
100 Nagog Park Acton, MA 01720
Telephone
Telephone
(+1) 978-600-7000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AACR Annual meeting

AACR Annual meeting

Not Confirmed

envelop Contact Supplier

AACR Annual meeting

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/marketing/insulets-omnipod-takes-type-2-diabetes-representation-tv-screen-scrubs-revival

FIERCE PHARMA
06 Apr 2026

https://investors.insulet.com/news/news-details/2023/Insulet-Announces-New-Organizational-Structure-to-Drive-Further-Growth/default.aspx

PRESS RELEASE
31 Mar 2026

https://www.businesswire.com/news/home/20260330524787/en/Insulet-Appoints-Mike-Panos-as-Chief-Commercial-Officer

BUSINESSWIRE
30 Mar 2026

https://www.businesswire.com/news/home/20260310196288/en/Insulet-to-Present-EVOLUTION-2-Results-on-Omnipod-Fully-Closed-Loop-System-for-Adults-with-Type-2-Diabetes-at-International-Conference-on-Advanced-Technologies-Treatments-for-Diabetes-ATTD

BUSSINESSWIRE
10 Mar 2026

https://www.businesswire.com/news/home/20260218828620/en/Insulet-Reports-Fourth-Quarter-and-Full-Year-2025-Results

BUSINESSWIRE
18 Feb 2026

https://www.businesswire.com/news/home/20260109369927/en/Insulet-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-18-2026

BUSINESSWIRE
09 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty